Your browser is no longer supported. Please, upgrade your browser.
Settings
NXTM Nxstage Medical, Inc. daily Stock Chart
NXTM [NASD]
Nxstage Medical, Inc.
Index- P/E- EPS (ttm)-0.39 Insider Own2.30% Shs Outstand63.24M Perf Week-2.91%
Market Cap906.86M Forward P/E- EPS next Y-0.26 Insider Trans-3.31% Shs Float61.74M Perf Month-10.04%
Income-24.30M PEG- EPS next Q-0.10 Inst Own97.80% Short Float7.50% Perf Quarter-20.42%
Sales308.80M P/S2.94 EPS this Y-25.80% Inst Trans1.76% Short Ratio9.06 Perf Half Y-19.57%
Book/sh3.01 P/B4.76 EPS next Y27.80% ROA-7.90% Target Price22.17 Perf Year0.49%
Cash/sh0.81 P/C17.78 EPS next 5Y20.00% ROE-12.90% 52W Range11.50 - 19.63 Perf YTD-20.02%
Dividend- P/FCF- EPS past 5Y16.00% ROI-11.60% 52W High-28.12% Beta0.70
Dividend %- Quick Ratio1.90 Sales past 5Y15.20% Gross Margin37.90% 52W Low22.70% ATR0.37
Employees3400 Current Ratio2.90 Sales Q/Q10.10% Oper. Margin-7.40% RSI (14)25.89 Volatility2.85% 2.49%
OptionableYes Debt/Eq0.09 EPS Q/Q0.00% Profit Margin-7.90% Rel Volume0.48 Prev Close14.34
ShortableYes LT Debt/Eq0.06 EarningsAug 06 BMO Payout- Avg Volume510.93K Price14.11
Recom1.90 SMA20-6.99% SMA50-13.53% SMA200-15.46% Volume66,072 Change-1.60%
May-03-13Reiterated Feltl & Co. Hold $11.50 → $12
Mar-01-13Reiterated Feltl & Co. Hold $13 → $11.50
Dec-04-12Downgrade Northland Securities Outperform → Market Perform
Sep-07-12Initiated Northland Securities Outperform $18
Feb-18-11Reiterated Rodman & Renshaw Mkt Underperform $15 → $18
Dec-03-10Initiated Jefferies Buy $27
Oct-14-10Downgrade Rodman & Renshaw Mkt Perform → Mkt Underperform $15
Sep-15-10Initiated Feltl & Co. Buy $19
Jul-26-10Downgrade Rodman & Renshaw Mkt Outperform → Mkt Perform
May-06-10Reiterated Rodman & Renshaw Mkt Outperform $11 → $14
Jan-08-10Initiated Rodman & Renshaw Mkt Outperform $11
Jun-05-09Upgrade William Blair Mkt Perform → Outperform
Aug-06-08Reiterated SMH Capital Buy $8 → $7
Aug-06-08Reiterated Canaccord Adams Hold $7 → $4.75
Jul-29-08Initiated SMH Capital Buy $8
May-14-08Reiterated JMP Securities Mkt Outperform $13 → $10
May-13-08Downgrade William Blair Outperform → Mkt Perform
May-13-08Downgrade Canaccord Adams Buy → Hold $12 → $7
Feb-13-08Reiterated SMH Capital Buy $18 → $13
Feb-13-08Reiterated JMP Securities Mkt Outperform $17 → $13
Jun-24-15 08:36AM  NxStage Kicks Off 10th Anniversary of Innovation Milestone with Summer-Long Celebration of Patient Life Achievements PR Newswire
Jun-18-15 08:22AM  New Study Finds Home Hemodialysis Patient Survival Rates Nearly Double Those of Peritoneal Dialysis PR Newswire
Jun-17-15 03:36PM  Deerfield Management Trims Holding In Antares Pharma Inc (ATRS) Just Before Disastrous Setback at Insider Monkey
Jun-16-15 08:00AM  NxStage Kidney Care To Host Grand Opening Event at Greenbelt Dialysis Center PR Newswire
Jun-03-15 09:15AM  Home Hemodialysis With NxStage System One Can Save California 221 Million Gallons of Water Annually PR Newswire
May-29-15 01:23PM  Deerfield Managements Top Health Stocks ~ Auspex Pharmaceuticals Inc (ASPX), Horizon Pharma PLC (HZNP), AbbVie Inc (ABBV) at Insider Monkey
May-27-15 04:05PM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Change in Directors or Principal Officers
May-20-15 10:24AM  NxStage Announces First Annual Zenith Award Winner PR Newswire
May-15-15 01:04PM  NXSTAGE MEDICAL, INC. Financials
May-13-15 08:00AM  NxStage Announces Second Quarter 2015 Investor Conference Schedule PR Newswire
May-11-15 02:10PM  NxStage Medical Loss Narrower than Expected, Revenues Up - Analyst Blog
May-08-15 08:09PM  10-Q for NxStage Medical, Inc. at Company Spotlight
May-06-15 09:19AM  NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance at noodls
09:00AM  NxStage Medical Inc Earnings Call scheduled for 9:00 am ET today
08:12AM  NxStage reports 1Q loss
08:07AM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh
07:59AM  NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance PR Newswire
07:07AM  Q1 2015 NxStage Medical Inc Earnings Release - Before Market Open
May-04-15 09:13AM  NxStage Establishes New Scientific Advisory Board to Build Clinical Evidence and Drive Adoption of Home Hemodialysis Therapy at noodls
08:00AM  NxStage Establishes New Scientific Advisory Board to Build Clinical Evidence and Drive Adoption of Home Hemodialysis Therapy PR Newswire
Apr-30-15 08:26AM  NxStage Kidney Care Opens Dialysis Center in Parkland, Florida at noodls
08:00AM  NxStage Kidney Care Opens Dialysis Center in Parkland, Florida PR Newswire
Apr-27-15 04:27PM  NxStage to Present at the 40th Annual Deutsche Bank Securities Health Care Conference at noodls
04:05PM  NxStage to Present at the 40th Annual Deutsche Bank Securities Health Care Conference PR Newswire
Apr-22-15 08:15AM  NxStage Kidney Care Brings Flexible Dialysis Therapy Options to North Orlando at noodls
08:00AM  NxStage Kidney Care Brings Flexible Dialysis Therapy Options to North Orlando PR Newswire
Apr-15-15 02:00PM  NxStage Medical Opens New Dialysis Center in Pittsburgh - Analyst Blog
Apr-14-15 08:38AM  NxStage Kidney Care Brings Dialysis Options to Pittsburgh Area at noodls
08:00AM  NxStage Kidney Care Brings Dialysis Options to Pittsburgh Area PR Newswire
Apr-07-15 08:18AM  NxStage® to Report First Quarter 2015 Financial Results at noodls
08:00AM  NxStage® to Report First Quarter 2015 Financial Results PR Newswire
Apr-01-15 06:31PM  NxStage Medical Opens New Dialysis Center in Maryland - Analyst Blog
Mar-31-15 08:08AM  NxStage Kidney Care Brings Innovative Dialysis Options to Prince George County at noodls
08:00AM  NxStage Kidney Care Brings Innovative Dialysis Options to Prince George County PR Newswire
Mar-26-15 06:37PM  NxStage Medical to Present Positive Data on System One - Analyst Blog
Mar-25-15 08:13AM  New Data Show Improved Survival, Reduced Cardiovascular Hospital Readmissions, and Increased Transplantation on Home Hemodialysis with the NxStage System One at noodls
08:00AM  New Data Show Improved Survival, Reduced Cardiovascular Hospital Readmissions, and Increased Transplantation on Home Hemodialysis with the NxStage System One PR Newswire
Mar-19-15 10:08AM  NxStage Celebrates Second Annual National Home Hemodialysis Day at noodls
08:00AM  NxStage Celebrates Second Annual National Home Hemodialysis Day PR Newswire
Mar-16-15 08:00AM  NxStage to Present Abstract on Home Nocturnal Therapy with System One at NKF 2015 Spring Clinical Meeting PR Newswire
Mar-11-15 08:53AM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Mar-04-15 03:16PM  NxStage to Present at the Barclays Capital Global Healthcare Conference at noodls
02:56PM  NxStage to Present at the Barclays Capital Global Healthcare Conference PR Newswire
08:49AM  NxStage Medical (NXTM) Q4 Loss Narrower than Expected - Analyst Blog
Feb-28-15 07:08PM  10-K for NxStage Medical, Inc. at Company Spotlight
Feb-26-15 01:21PM  NxStage Reports Record Fourth Quarter and Full-Year 2014 Revenue at noodls
09:00AM  NxStage Medical Inc Earnings Call scheduled for 9:00 am ET today
07:46AM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh
07:27AM  NxStage Reports Record Fourth Quarter and Full-Year 2014 Revenue PR Newswire
07:07AM  Q4 2014 NxStage Medical Inc Earnings Release - Before Market Open CCBN
Feb-25-15 01:27PM  NxStage opens first two kidney care centers in Massachusetts at bizjournals.com
08:00AM  NxStage Kidney Care Brings Flexible Therapy Options To Greater Boston Area PR Newswire
Feb-09-15 05:05PM  Medtronic's Pipeline Flex Embolization Device Gets FDA Nod - Analyst Blog Zacks
Feb-02-15 08:00AM  NxStage Hosts Panel Discussion on Home Nocturnal Hemodialysis at 2015 Annual Dialysis Conference PR Newswire
Jan-30-15 01:50PM  Abaxis (ABAX) Beats Q3 Earnings, Revenues; Margin Grows - Analyst Blog Zacks
Jan-29-15 05:20PM  Baxter (BAX) Beats Q4 Earnings Estimates, Sales Up Y/Y - Analyst Blog Zacks
11:09AM  Mead Johnson's US Expansion Drives Q4 Earnings Beat - Analyst Blog Zacks
Jan-28-15 12:30PM  St. Jude Q4 Earnings Meet Estimates on Modest Sales Growth - Analyst Blog Zacks
08:21AM  Stryker Lags Q4 Earnings, Revenue Estimates - Analyst Blog Zacks
08:00AM  NxStage® to Report Fourth Quarter and Full Year 2014 Financial Results PR Newswire
Jan-20-15 08:00AM  NxStage Establishes Annual Zenith Award To Recognize Excellence in Acute Renal Care PR Newswire
Jan-14-15 05:15PM  NxStage Revises Up 2014 Guidance on Strong Home Growth - Analyst Blog Zacks
Jan-13-15 09:17AM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh EDGAR Online
08:00AM  NxStage Increases Revenue Guidance for the Fourth Quarter and Full-Year 2014 PR Newswire
Dec-22-14 07:07AM  NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis PR Newswire
Dec-19-14 08:00AM  NxStage Founder and CEO Discusses Innovation in Healthcare at EY Boston Life Sciences Summit PR Newswire
Dec-18-14 09:00AM  NxStage to Present at the 33rd Annual J.P. Morgan Healthcare Conference PR Newswire
Nov-26-14 05:00PM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
09:31AM  NxStage Medical (NXTM) Upgraded From Sell to Hold at TheStreet
Nov-21-14 05:30PM  NxStage Medical Unveils Streamline Express Dialyzer Zacks
Nov-18-14 08:45AM  NxStage Launches New Streamline Express Dialyzer With Pre-attached Blood Tubing Set PR Newswire
Nov-11-14 07:00AM  New Data Demonstrates Significant Advantage in Mortality, Hospitalization, and Patient Dropout with NxStage Home Hemodialysis when Compared with Peritoneal Dialysis PR Newswire
Nov-09-14 07:09PM  10-Q for NxStage Medical, Inc. Company Spotlight
Nov-07-14 04:17PM  NXSTAGE MEDICAL, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
08:00AM  NxStage Announces Fourth Quarter 2014 Investor Conference Schedule PR Newswire
Nov-06-14 07:43AM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh EDGAR Online +8.29%
07:31AM  NxStage Reports Record Third Quarter 2014 Financial Results And Raises Full-Year Revenue Guidance PR Newswire
07:07AM  Q3 2014 NxStage Medical Inc Earnings Release - Before Market Open CCBN
Nov-04-14 04:01PM  NxStage Announces Winner of First Annual Nurse Hero Campaign PR Newswire
Oct-30-14 08:00AM  Grand Opening of NxStage Kidney Care Oak Brook IL Center PR Newswire
Oct-29-14 05:09PM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Termination of a Material Definitive Agreement EDGAR Online
Oct-24-14 08:00AM  NxStage Director of Public Policy Honored for Dedication to Patient Advocacy PR Newswire
Oct-08-14 09:57AM  NxStage Kidney Care Hosts Grand Opening Event at Florida Dialysis Center PR Newswire
Oct-07-14 08:00AM  NxStage® to Report Third Quarter 2014 Financial Results PR Newswire
Oct-01-14 05:01PM  NXSTAGE MEDICAL, INC. Files SEC form 10-Q/A, Quarterly Report EDGAR Online
Sep-16-14 08:00AM  NxStage Announces FDA Clearance of Single Needle Technology PR Newswire
Sep-10-14 08:00AM  NxStage Patients Participate in 257-Mile Tour DaVita Bike Ride PR Newswire
Aug-20-14 10:00AM  NxStage Kidney Care Opens New Orlando Florida Dialysis Center PR Newswire
Aug-12-14 08:00AM  Allan J. Collins, M.D., to join NxStage as Senior Medical Advisor PR Newswire
Aug-07-14 08:07AM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh EDGAR Online +5.98%
07:54AM  NXSTAGE MEDICAL, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
07:38AM  NxStage Reports Record Second Quarter 2014 Financial Results And Increases Full-Year Revenue Guidance PR Newswire
07:07AM  Q2 2014 NxStage Medical, Inc. Earnings Release - Before Market Open CCBN
Aug-01-14 08:00AM  NxStage to Present at the 34th Annual Canaccord Genuity Growth Conference PR Newswire
Jul-17-14 08:01AM  NxStage® to Report Second Quarter 2014 Financial Results PR Newswire
Jul-16-14 10:09AM  NxStage Drives to Educate Kidney Patients PR Newswire
Jul-08-14 05:35PM  Mariel Therapeutics Acquires Stryker Assets Zacks
08:00AM  NxStage Kidney Care Hosts Grand Opening Celebration Of New State-Of-The-Art Dialysis Center In Jacksonville PR Newswire
Jul-03-14 11:31AM  NxStage Joins Patients in Celebrating Independence PR Newswire
08:15AM  NxStage Medical reiterated Outperform after CMS rule at William Blair at theflyonthewall.com
NxStage Medical, Inc., a medical device company, develops, manufactures, and markets products for the treatment of kidney failure, fluid overload, and related blood treatments and procedures. Its primary product includes the System One, a portable hemodialysis system used for the treatment of acute and chronic kidney failure, and fluid overload. The company operates in three segments: System One, In-Center, and Services. The System One segment engages in the sale and rental of the NxStage System One and PureFlow SL dialysate preparation equipment, and sale of disposable products in the home and critical care markets. The home market focuses on the treatment of end-stage renal disease (ESRD) patients in the home or a home-like setting, and critical care market on the treatment of hospital-based patients with acute kidney failure or fluid overload. The In-Center segment sells blood tubing sets and needles for hemodialysis primarily for the treatment of ESRD patients at dialysis centers; and needles for apheresis. The Services segment provides dialysis services to patients at NxStage Kidney Care dialysis centers. NxStage Medical, Inc. markets its products through direct sales and distributors to hospitals and dialysis centers in the United States and internationally. The company, formerly known as QB Medical, Inc., was founded in 1998 and is headquartered in Lawrence, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Turk Joseph E JrPresidentJun 23Sale15.362,00030,720116,163Jun 24 04:07 PM
Swan Winifred LSVP and General CounselJun 15Option Exercise9.966206,17528,099Jun 16 04:35 PM
Swan Winifred LSVP and General CounselJun 15Sale15.482,50038,70025,599Jun 16 04:35 PM
Turk Joseph E JrPresidentJun 10Option Exercise7.971,33910,675121,002Jun 10 06:35 PM
Turk Joseph E JrPresidentJun 10Sale16.002,83945,424118,163Jun 10 06:35 PM
Turk Joseph E JrPresidentMay 26Sale16.642,00033,280119,663May 28 04:07 PM
MOORE CRAIG WDirectorMay 20Option Exercise13.8814,000194,320109,524May 22 04:14 PM
Swan Winifred LSVP and General CounselMay 18Option Exercise9.966206,17529,979May 19 04:56 PM
Swan Winifred LSVP and General CounselMay 18Sale16.652,50041,62527,479May 19 04:56 PM
Swan Winifred LSVP and General CounselMay 14Sale16.335008,16529,359May 15 04:35 PM
Turk Joseph E JrPresidentMay 13Option Exercise2.11150317123,313May 15 04:35 PM
Turk Joseph E JrPresidentMay 13Sale16.311,65026,912121,663May 15 04:35 PM
Burbank Jeffrey HChief Executive OfficerMay 12Option Exercise2.1110,00021,100886,756May 13 04:42 PM
Burbank Jeffrey HChief Executive OfficerMay 12Sale16.4410,000164,400876,756May 13 04:42 PM
Turk Joseph E JrPresidentApr 21Option Exercise8.729508,285125,113Apr 22 04:35 PM
Turk Joseph E JrPresidentApr 21Sale18.401,95035,880123,163Apr 22 04:35 PM
Burbank Jeffrey HChief Executive OfficerApr 16Option Exercise2.1110,00021,100886,756Apr 17 04:42 PM
Burbank Jeffrey HChief Executive OfficerApr 16Sale18.3110,000183,100876,756Apr 17 04:42 PM
Swan Winifred LSVP and General CounselApr 15Sale18.415009,20529,859Apr 17 04:28 PM
Turk Joseph E JrPresidentMar 31Option Exercise9.968007,968126,463Apr 02 05:21 PM
Turk Joseph E JrPresidentMar 31Sale17.5080014,000125,663Apr 02 05:21 PM
Turk Joseph E JrPresidentMar 26Option Exercise2.11150317126,813Mar 30 04:42 PM
Turk Joseph E JrPresidentMar 26Sale16.941,15019,481125,663Mar 30 04:42 PM
Swan Winifred LSVP and General CounselMar 19Sale17.315008,65530,359Mar 20 05:28 PM
Turk Joseph E JrPresidentMar 17Option Exercise4.54136617126,799Mar 19 04:28 PM
REID PERPERDirectorMar 17Option Exercise13.8814,000194,320130,911Mar 19 04:28 PM
Turk Joseph E JrPresidentMar 17Sale16.571362,254126,663Mar 19 04:28 PM
Giannini Daniel ADirectorMar 13Option Exercise13.8814,000194,32081,540Mar 17 05:35 PM
Turk Joseph E JrPresidentMar 10Sale16.441,50024,660126,663Mar 11 05:14 PM
Swan Winifred LSVP and General CounselMar 04Option Exercise0.003,675032,054Mar 05 08:14 PM
Brown Robert S.President, NxStage Kidney CareMar 04Option Exercise0.003,675060,972Mar 05 07:56 PM
Burbank Jeffrey HChief Executive OfficerMar 04Option Exercise0.0010,1070880,942Mar 05 06:21 PM
Turk Joseph E JrPresidentMar 03Option Exercise0.0413,553599132,658Mar 05 07:07 PM
Burbank Jeffrey HChief Executive OfficerMar 03Option Exercise0.0028,0210879,942Mar 05 06:21 PM
Brown Robert S.President, NxStage Kidney CareMar 03Option Exercise0.009,746060,428Mar 05 07:56 PM
TOWSE MATTHEW WSVP and Chief Financial OfficeMar 03Option Exercise0.009,746022,023Mar 05 07:28 PM
Swan Winifred LSVP and General CounselMar 03Option Exercise0.007,919030,950Mar 05 08:14 PM
Turk Joseph E JrPresidentMar 03Sale17.051322,251129,358Mar 05 07:07 PM
Turk Joseph E JrPresidentFeb 25Option Exercise8.211,0828,884113,657Feb 26 05:28 PM
Turk Joseph E JrPresidentFeb 25Sale17.882,08237,226111,575Feb 26 05:28 PM
LEWIS EARL RDirectorFeb 20Option Exercise13.8814,000194,32067,145Feb 20 04:07 PM
Swan Winifred LSVP and General CounselFeb 18Sale17.605008,80017,688Feb 20 04:07 PM
Turk Joseph E JrPresidentFeb 11Sale17.561,50026,340112,575Feb 13 04:56 PM
Turk Joseph E JrPresidentJan 27Option Exercise7.481,35010,101116,425Jan 28 06:07 PM
Turk Joseph E JrPresidentJan 27Sale18.702,35043,945114,075Jan 28 06:07 PM
Swan Winifred LSVP and General CounselJan 14Sale18.445009,22018,188Jan 14 05:07 PM
Swan Winifred LSVP and General CounselJan 13Option Exercise0.00666019,354Jan 14 05:07 PM
Turk Joseph E JrPresidentJan 13Sale18.351,50027,525115,075Jan 14 05:07 PM
Swan Winifred LSVP and General CounselJan 13Sale18.3566612,22118,688Jan 14 05:07 PM
Turk Joseph E JrPresidentDec 31Option Exercise4.544,62821,011116,575Jan 05 05:17 PM
Swan Winifred LSVP and General CounselDec 29Option Exercise6.846674,56219,355Dec 31 07:57 PM
Swan Winifred LSVP and General CounselDec 29Sale18.1766712,11918,688Dec 31 07:57 PM
Turk Joseph E JrPresidentDec 23Option Exercise7.481,35010,101114,297Dec 23 07:34 PM
Turk Joseph E JrPresidentDec 23Sale18.442,35043,334111,947Dec 23 07:34 PM
Swan Winifred LSVP and General CounselDec 22Option Exercise6.846674,56219,355Dec 23 07:13 PM
Swan Winifred LSVP and General CounselDec 22Sale18.6166712,41318,688Dec 23 07:13 PM
Swan Winifred LSVP and General CounselDec 18Sale18.255009,12518,688Dec 19 07:18 PM
Turk Joseph E JrPresidentDec 15Option Exercise6.842,00013,680114,947Dec 16 04:48 PM
Hershberger KevinChief Accounting OfficerDec 15Sale17.453,00052,35018,485Dec 16 04:26 PM
Turk Joseph E JrPresidentDec 15Sale17.452,00034,900112,947Dec 16 04:48 PM
Hershberger KevinChief Accounting OfficerDec 12Option Exercise9.965,00049,80026,485Dec 16 04:26 PM
Hershberger KevinChief Accounting OfficerDec 12Sale17.045,00085,20021,485Dec 16 04:26 PM
Turk Joseph E JrPresidentDec 10Sale17.771,50026,655112,947Dec 11 05:03 PM
Burbank Jeffrey HCEODec 05Sale17.165,00085,800833,083Dec 08 05:41 PM
Brown Robert S.President, Kidney CareDec 03Option Exercise14.443004,33247,928Dec 04 07:55 PM
Brown Robert S.President, Kidney CareDec 03Sale17.483005,24447,628Dec 04 07:55 PM
Brown Robert S.President, Kidney CareDec 02Option Exercise14.4434,700501,06882,328Dec 02 08:02 PM
Brown Robert S.President, Kidney CareDec 02Sale17.4434,700605,16847,628Dec 02 08:02 PM
Swan Winifred LSVP and General CounselDec 01Option Exercise14.4416,667240,67135,855Dec 02 07:26 PM
Turk Joseph E JrPresidentDec 01Option Exercise14.4424,762357,563139,209Dec 02 07:37 PM
Swan Winifred LSVP and General CounselDec 01Sale17.0416,667284,00619,188Dec 02 07:26 PM
Turk Joseph E JrPresidentDec 01Sale17.0424,762421,944114,447Dec 02 07:37 PM
Turk Joseph E JrPresidentNov 25Option Exercise7.212,35016,941117,797Nov 25 07:38 PM
Turk Joseph E JrPresidentNov 25Sale17.593,35058,927114,447Nov 25 07:38 PM
Burbank Jeffrey HCEONov 24Option Exercise14.44120,0001,732,800936,481Nov 25 07:59 PM
Turk Joseph E JrPresidentNov 14Option Exercise14.4424,760357,534140,207Nov 17 05:40 PM
Swan Winifred LSVP and General CounselNov 14Option Exercise14.4416,667240,67136,355Nov 17 05:42 PM
Swan Winifred LSVP and General CounselNov 14Sale17.3717,167298,19119,188Nov 17 05:42 PM
Turk Joseph E JrPresidentNov 14Sale17.3724,760430,081115,447Nov 17 05:40 PM
Turk Joseph E JrPresidentNov 13Option Exercise9.964,80047,808120,247Nov 17 05:40 PM
Turk Joseph E JrPresidentNov 13Sale17.504,80084,000115,447Nov 17 05:40 PM
Hershberger KevinChief Accounting OfficerNov 12Option Exercise9.967,82477,92732,541Nov 12 06:58 PM
Hershberger KevinChief Accounting OfficerNov 12Sale16.5811,056183,30821,485Nov 12 06:58 PM
Turk Joseph E JrPresidentNov 12Sale16.581,50024,870115,447Nov 12 05:45 PM
Turk Joseph E JrPresidentNov 07Option Exercise14.4424,761357,549141,708Nov 12 05:45 PM
Turk Joseph E JrPresidentNov 07Sale16.2524,761402,366116,947Nov 12 05:45 PM
Swan Winifred LSVP and General CounselNov 05Option Exercise9.9612,000119,52031,688Nov 07 05:14 PM
Swan Winifred LSVP and General CounselNov 05Sale15.3012,000183,60019,688Nov 07 05:14 PM
Turk Joseph E JrPresidentNov 03Option Exercise14.445,71782,553122,664Nov 04 04:58 PM
Turk Joseph E JrPresidentNov 03Sale15.505,71788,614116,947Nov 04 04:58 PM
Brown Robert S.President, Kidney CareOct 23Option Exercise4.5443,470197,35491,098Oct 24 06:10 PM
Brown Robert S.President, Kidney CareOct 23Sale14.5343,470631,61947,628Oct 24 06:10 PM
Brown Robert S.President, Kidney CareOct 22Option Exercise4.541,9008,62649,528Oct 24 06:10 PM
Brown Robert S.President, Kidney CareOct 22Sale14.501,90027,55047,628Oct 24 06:10 PM
Turk Joseph E JrPresidentOct 20Sale14.001,50021,000117,947Oct 21 06:24 PM
Burbank Jeffrey HCEOOct 20Sale14.007,584106,176821,481Oct 22 04:26 PM
Swan Winifred LSVP and General CounselOct 15Option Exercise6.842,96820,30123,156Oct 17 04:34 PM
Swan Winifred LSVP and General CounselOct 15Sale13.013,46845,11919,688Oct 17 04:34 PM
Turk Joseph E JrPresidentSep 24Option Exercise6.202,55015,813122,997Sep 26 05:22 PM
Turk Joseph E JrPresidentSep 24Sale13.343,55047,357119,447Sep 26 05:22 PM